NewEdge Advisors’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $438K | Buy |
34,190
+1,690
| +5% | +$21.6K | ﹤0.01% | 1773 |
|
|
2025
Q1 | $412K | Buy |
32,500
+9,785
| +43% | +$124K | ﹤0.01% | 1694 |
|
|
2024
Q4 | $298K | Sell |
22,715
-1,201
| -5% | -$15.8K | ﹤0.01% | 1884 |
|
|
2024
Q3 | $361K | Sell |
23,916
-3,827
| -14% | -$57.7K | ﹤0.01% | 1677 |
|
|
2024
Q2 | $393K | Buy |
27,743
+2,779
| +11% | +$39.4K | ﹤0.01% | 1556 |
|
|
2024
Q1 | $340K | Buy |
24,964
+2,463
| +11% | +$33.6K | ﹤0.01% | 1572 |
|
|
2023
Q4 | $314K | Sell |
22,501
-3,407
| -13% | -$47.6K | ﹤0.01% | 1531 |
|
|
2023
Q3 | $323K | Sell |
25,908
-4,994
| -16% | -$62.3K | ﹤0.01% | 1388 |
|
|
2023
Q2 | $418K | Buy |
30,902
+1,817
| +6% | +$24.6K | ﹤0.01% | 1276 |
|
|
2023
Q1 | $401K | Buy |
29,085
+861
| +3% | +$11.9K | 0.01% | 1208 |
|
|
2022
Q4 | $378K | Buy |
28,224
+130
| +0.5% | +$1.74K | 0.01% | 902 |
|
|
2022
Q3 | $384K | Buy |
28,094
+1,564
| +6% | +$21.4K | 0.01% | 1085 |
|
|
2022
Q2 | $378K | Buy |
26,530
+2,431
| +10% | +$34.6K | 0.01% | 1101 |
|
|
2022
Q1 | $398K | Buy |
24,099
+9,500
| +65% | +$157K | 0.01% | 897 |
|
|
2021
Q4 | $281K | Buy |
+14,599
| New | +$281K | ﹤0.01% | 1360 |
|